Please assess the completion status of the following clinical trial:

Trial Title: High Volume Injection or Autologous Conditioned Plasma (ACP) in Chronic Achilles Tendinopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Clinically and ultrasound diagnosed unilateral midt-tendinous achilles tendinopathy~* Symptoms \> 3 month~* No steroid injections \< 6 month~* 60 males with BMI \<30 between 18-60 years.~Exclusion Criteria:~* Bilateral achilles tendinopathy~* Insertional tendinopathy~* Steroid injections \< 6 month~* Diabetes or cardiovascular disease~* Smoking~* Treatment with fluoroquinolones \< 6 month

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- High Volume injection (Type: ACTIVE_COMPARATOR): A total volume of 50 ml:~* 10 mls 0.5% bupivacaine hydrochloride and~* 20 mg of Depomedrol (hydrocortisone)~* 40 mls saline (NaCl) HVI is injected one time at baseline and thereafter the group received sham treatment at 2 weeks, 4 weeks and after 6 weeks.
- Autologous conditioned plasma (ACP) (Type: ACTIVE_COMPARATOR): Whole blood was drawn from the patients using arthrex system (total of 10 mls whole blood). After that the whole blood is spined for 5 minutes and ACP with platelets and growth factors is separated from the red and white blood cells (4 mls).~The ACP is injected 4 times (at baseline, 2 weeks, 4 weeks and after 6 weeks)
- Placebo (Type: SHAM_COMPARATOR): A few drops of saline is injected in the soft tissue away from the tendon.

Based on this trial design, predict the completion outcome and termination type (if applicable).